Mutations of the VHL tumour suppressor gene in renal carcinoma

J. R. Gnarra, K. Tory, Y. Weng, L. Schmidt, M. H. Wei, H. Li, F. Latif, S. Liu, F. Chen, F. M. Duh, I. Lubensky, D. R. Duan, C. Florence, R. Pozzatti, M. M. Walther, N. H. Bander, H. B. Grossman, H. Brauch, S. Pomer, J. D. BrooksW. B. Isaacs, M. I. Lerman, B. Zbar, W. M. Linehan

Research output: Contribution to journalArticlepeer-review

Abstract

Multiple, bilateral renal carcinomas are a frequent occurrence in von Hippel–Lindau (VHL) disease. To elucidate the aetiological role of the VHL gene in human kidney tumorigenesis, localized and advanced tumours from 110 patients with sporadic renal carcinoma were analysed for VHL mutations and loss of heterozygosity (LOH). VHL mutations were identified in 57% of clear cell renal carcinomas analysed and LOH was observed in 98% of those samples. Moreover, VHL was mutated and lost in a renal tumour from a patient with familial renal carcinoma carrying the constitutional translocation, t(3;8)(p14;q24). The identification of VHL mutations in a majority of localized and advanced sporadic renal carcinomas and in a second form of hereditary renal carcinoma indicates that the VHL gene plays a critical part in the origin of this malignancy.

Original languageEnglish (US)
Pages (from-to)85-90
Number of pages6
JournalNature genetics
Volume7
Issue number1
DOIs
StatePublished - May 1994

ASJC Scopus subject areas

  • Genetics

Fingerprint

Dive into the research topics of 'Mutations of the VHL tumour suppressor gene in renal carcinoma'. Together they form a unique fingerprint.

Cite this